![Ivan Bergstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Bergstein
Chief Executive Officer at
STEMLINE THERAPEUTICS, INC.
Profile
Dr. Ivan Bergstein, MD, is a President & Chief Executive Officer at Stemline Therapeutics, Inc.
Dr. Bergstein was previously employed as a Chairman by Lirum Therapeutics, Inc., a Medical Director by ACCESS Oncology, Inc., a Medical Director by Keryx Biopharmaceuticals, Inc., and a Senior Biopharmaceuticals Analyst by Nitron Advisors.
He received his undergraduate degree from the University of Pennsylvania and a doctorate degree from Icahn School of Medicine at Mount Sinai.
Ivan Bergstein active positions
| Companies | Position | Start |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Chief Executive Officer | - |
Former positions of Ivan Bergstein
| Companies | Position | End |
|---|---|---|
| LIRUM THERAPEUTICS, INC. | Chairman | - |
Nitron Advisors
 Nitron Advisors Investment ManagersFinance Operates investment research company | Corporate Officer/Principal | - |
| KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | - |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Chief Tech/Sci/R&D Officer | - |
Education of Ivan Bergstein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nitron Advisors
Nitron Advisors Investment ManagersFinance Operates investment research company | Finance |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that focuses on the treatment of debilitating diseases | Commercial Services |
- Stock Market
- Insiders
- Ivan Bergstein
